Lataa...
Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women
For more than 20 years, tamoxifen has been the gold standard for the adjuvant treatment of postmenopausal women with hormone-responsive early breast cancer. However, recent randomized trials have shown efficacy and tolerability benefits with the third-generation aromatase inhibitor anastrozole, resu...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2690973/ https://ncbi.nlm.nih.gov/pubmed/19753124 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|